Screening and identification of a phage display derived peptide that specifically binds to the CD44 protein region encoded by variable exons

Journal of Biomolecular Screening

Volumn 21, Issue 1, 2016, Pages 44-53

  Zhang, Dan ^a   Jia, Huan ^b   Li, Weiming ^a   Hou, Yingchun ^c   Lu, Shaoying ^a   He, Shuixiang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

^c SHAANXI NORMAL UNIVERSITY   (China)

Author keywords

cancer targeting; CD44v; peptide probe; phage display

Indexed keywords

CD44V ANTIGEN; CD44 PROTEIN, HUMAN; HERMES ANTIGEN; PEPTIDE; PEPTIDE LIBRARY; PROTEIN BINDING;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; CANCER TISSUE; COMPETITIVE INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR IMAGING; PEPTIDE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; STOMACH CANCER; BACTERIOPHAGE; BINDING COMPETITION; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANTIGENS, CD44; BACTERIOPHAGES; BINDING, COMPETITIVE; CELL LINE; CELL LINE, TUMOR; EXONS; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 84950975199     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057115608604     Document Type: Article

References (31)

1. Misra S., Heldin P., Hascall V.C., et al. Hyaluronan-cd44 Interactions as Potential Targets for Cancer Therapy. FEBS J. 2011, 278, 1429-1443.
2. Haynes B. F., Telen M. J., Hale L. P., et al. Cd44-A Molecule Involved in Leukocyte Adherence and T-Cell Activation. Immunol. Today 1989, 10, 423-428.
3. Goodison S., Urquidi V., Tarin D., Cd44 Cell Adhesion Molecules. Mol. Pathol. 1999, 52, 189-196.
4. Ponta H., Sherman L., Herrlich P. A., Cd44: From Adhesion Molecules to Signalling Regulators. Nat. Rev. Mol. Cell Biol. 2003, 4, 33-45.
5. Griffioen A. W., Coenen M. J., Damen C. A., et al. Cd44 Is Involved in Tumor Angiogenesis: An Activation Antigen on Human Endothelial Cells. Blood 1997, 90, 1150-1159.
6. Mayer B., Jauch K. W., Gunthert U., et al. De-Novo Expression of cd44 and Survival in Gastric Cancer. Lancet 1993, 342, 1019-1022.
7. Harn H. J., Ho L. I., Chang J. Y., et al. Differential Expression of the Human Metastasis Adhesion Molecule cd44v in Normal and Carcinomatous Stomach Mucosa of Chinese Subjects. Cancer 1995, 75, 1065-1071.
8. Castella E. M., Ariza A., Pellicer I., et al. Differential Expression of cd44v6 in Metastases of Intestinal and Diffuse Types of Gastric Carcinoma. J. Clin. Pathol. 1998, 51, 134-137.
9. Fan X., Long A., Goggins M., et al. Expression of cd44 and Its Variants on Gastric Epithelial Cells of Patients with Helicobacter pylori Colonisation. Gut 1996, 38, 507-512.
10. Washington K., Gottfried M. R., Telen M. J., Expression of the Cell Adhesion Molecule cd44 in Gastric Adenocarcinomas. Hum. Pathol. 1994, 25, 1043-1049.
11. Kim Y. S., Chi S. G., Kim Y. W., et al. Molecular Genetic Characterization of Alternatively Spliced cd44 Transcripts in Human Stomach Carcinoma. J. Korean Med. Sci. 1997, 12, 505-513.
12. Yamaguchi A., Saito M., Gio T., et al. Expression of cd44 Variant Exons 8-10 in Gastric Cancer. Jpn. J. Cancer Res. 1995, 86, 1166-1171.
13. Yasui W., Kudo Y., Naka K., et al. Expression of cd44 Containing Variant Exon 9 (cd44v9) in Gastric Adenomas and Adenocarcinomas: Relation to the Proliferation and Progression. Int. J. Oncol. 1998, 12, 1253-1258.
14. Li S. D., Howell S. B., Cd44-Targeted Microparticles for Delivery of Cisplatin to Peritoneal Metastases. Mol. Pharm. 2010, 7, 280-290.
15. Rupp U., Schoendorf-Holland E., Eichbaum M., et al. Safety and Pharmacokinetics of Bivatuzumab Mertansine in Patients with cd44v6-Positive Metastatic Breast Cancer: Final Results of a Phase I Study. Anticancer. Drugs 2007, 18, 477-485.
16. Serafino A., Zonfrillo M., Andreola F., et al. Cd44-Targeting for Antitumor Drug Delivery: A New sn-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis. Current Cancer Drug Targets 2011, 11, 572-585.
17. Park H. Y., Lee K. J., Lee S. J., et al. Screening of Peptides Bound to Breast Cancer Stem Cell Specific Surface Marker cd44 by Phage Display. Mol. Biotechnol. 2012, 51, 212-220.
18. D'Onofrio N., Caraglia M., Grimaldi A., et al. Vascular-Homing Peptides for Targeted Drug Delivery and Molecular Imaging: Meeting the Clinical Challenges. Biochim. Biophys. Acta 2014, 1846, 1-12.
19. Joshi B. P., Wang T. D., Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-Modal Imaging. Cancers (Basel) 2010, 2, 1251-1287.
20. Miller S. J., Joshi B. P., Feng Y., et al. In Vivo Fluorescence-Based Endoscopic Detection of Colon Dysplasia in the Mouse Using a Novel Peptide Probe. PLoS One 2011, 6, e17384.
21. Kim S., Kim D., Jung H. H., et al. Bio-Inspired Design and Potential Biomedical Applications of a Novel Class of High-Affinity Peptides. Angew. Chem. Int. Ed. Engl. 2012, 51, 1890-1894.
22. Markwalder R., Reubi J. C., Gastrin-Releasing Peptide Receptors in the Human Prostate: Relation to Neoplastic Transformation. Cancer Res. 1999, 59, 1152-1159.
23. Smith G. P., Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion Surface. Science 1985, 228, 1315-1317.
24. Jiang Z., Hu P., Liu J., et al. Screening Preoperative Peptide Biomarkers for Predicting Postoperative Myocardial Infarction after Coronary Artery Bypass Grafting. PLoS One 2014, 9, e100149.
25. Guo Y., Ma C., Li C., et al. Screening and Identification of a Specific Peptide Binding to Hepatocellular Carcinoma Cells from a Phage Display Peptide Library. J. Pept. Sci. 2014, 20, 196-202.
26. Kim D., Lee I. H., Kim S., et al. A Specific stat3-Binding Peptide Exerts Antiproliferative Effects and Antitumor Activity by Inhibiting stat3 Phosphorylation and Signaling. Cancer Res. 2014, 74, 2144-2151.
27. Kim T., Vidal G. S., Djurisic M., et al. Human lilrb2 Is a Beta-Amyloid Receptor and Its Murine Homolog pirb Regulates Synaptic Plasticity in an Alzheimer's Model. Science 2013, 341, 1399-1404.
28. Friedrichs K., Gluba S., Eidtmann H., et al. Overexpression of p53 and Prognosis in Breast Cancer. Cancer 1993, 72, 3641-3647.
29. Verel I., Heider K. H., Siegmund M., et al. Tumor Targeting Properties of Monoclonal Antibodies with Different Affinity for Target Antigen cd44v6 in Nude Mice Bearing Head-and-Neck Cancer Xenografts. Int. J. Cancer 2002, 99, 396-402.
30. Atreya R., Goetz M., Molecular Imaging in Gastroenterology. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 704-712.
31. Hibino S., Shibuya M., Engbring J. A., et al. Identification of an Active Site on the Laminin alpha5 Chain Globular Domain That Binds to cd44 and Inhibits Malignancy. Cancer Res. 2004, 64, 4810-4816.